Resultados da busca - Jon Weingart
- Mostrando 1 - 20 resultados de 22
- Ir para a próxima página
-
1
-
2
-
3
Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study por Jaishri O. Blakeley, Jeffrey J. Olson, Stuart A. Grossman, Xiaoying He, Jon Weingart, Jeffrey G. Supko
Publicado em 2008Artigo -
4
Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival por Kaisorn L. Chaichana, Khan Chaichana, Alessandro Olivi, Jon Weingart, Richard G. Bennett, Henry Brem, Alfredo Quiñones‐Hinojosa
Publicado em 2010Artigo -
5
-
6
Identification of der(1;19)(q10;p10) in Five Oligodendrogliomas Suggests Mechanism of Concurrent 1p and 19q Loss por Constance A. Griffin, Peter C. Burger, Laura Morsberger, Raluca Yonescu, Sharon L. Swierczynski, Jon Weingart, Kathleen M. Murphy
Publicado em 2006Artigo -
7
-
8
Supratentorial Glioblastoma Multiforme: The Role of Surgical Resection Versus Biopsy Among Older Patients por Kaisorn L. Chaichana, Tomás Garzón-Muvdi, Paul Park, Jon Weingart, Alessandro Olivi, Richard G. Bennett, Henry Brem, Alfredo Quiñones‐Hinojosa
Publicado em 2010Artigo -
9
-
10
The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival por Kaisorn L. Chaichana, Hasan A. Zaidi, Courtney Pendleton, Matthew J. McGirt, Rachel Grossman, Jon Weingart, Alessandro Olivi, Alfredo Quiñones‐Hinojosa, Henry Brem
Publicado em 2011Artigo -
11
Impact of COVID-19 on an Academic Neurosurgery Department: The Johns Hopkins Experience por Adham M. Khalafallah, Adrian E. Jimenez, Ryan P. Lee, Jon Weingart, Nicholas Theodore, Alan R. Cohen, Rafael J. Tamargo, Judy Huang, Henry Brem, Debraj Mukherjee
Publicado em 2020Artigo -
12
A clinicopathologic reappraisal of brain stem tumor classification por Paul G. Fisher, Steven N. Breiter, Benjamin S. Carson, Moody D. Wharam, Jeffery A. Williams, Jon Weingart, Dana R. Foer, Patricia T. Goldthwaite, Tarık Tihan, Peter C. Burger
Publicado em 2000Artigo -
13
Phase I Trial of Polifeprosan 20 With Carmustine Implant Plus Continuous Infusion of Intravenous <i>O</i><sup>6</sup>-Benzylguanine in Adults With Recurrent Malignant Glioma: New A... por Jon Weingart, Stuart A. Grossman, Kathryn A. Carson, Joy Fisher, Shannon M. Delaney, Mark L. Rosenblum, Alessandro Olivi, Kevin Judy, Stephen B. Tatter, M. Eileen Dolan
Publicado em 2007Artigo -
14
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme por Matthew J. McGirt, Khoi D. Than, Jon Weingart, Kaisorn L. Chaichana, Frank J. Attenello, Alessandro Olivi, John Laterra, Lawrence Kleinberg, Stuart A. Grossman, Henry Brem, Alfredo Quiñones‐Hinojosa
Publicado em 2008Artigo -
15
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft por Alexandra Borodovsky, Vafi Salmasi, Şevin Turcan, Armida W. M. Fabius, Gilson S. Baía, Charles G. Eberhart, Jon Weingart, Gary L. Gallia, Stephen B. Baylin, Timothy A. Chan, Gregory J. Riggins
Publicado em 2013Artigo -
16
Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors por Kaisorn L. Chaichana, Courtney Pendleton, Christopher M. Jackson, Juan Carlos Martínez-Gutiérrez, Andrea Diaz‐Stransky, J Aguayo, Alessandro Olivi, Jon Weingart, Gary L. Gallia, Michael Lim, Henry Brem, Alfredo Quiñones‐Hinojosa
Publicado em 2013Artigo -
17
Multidisciplinary Approach for Improved Outcomes in Secondary Cranial Reconstruction por Chad R. Gordon, Mark Fisher, Jason Liauw, Ioan Lina, Varun Puvanesarajah, Srinivas M. Susarla, Alexander L. Coon, Michael Lim, Alfredo Quiñones‐Hinojosa, Jon Weingart, Geoffrey P. Colby, Alessandro Olivi, Judy Huang
Publicado em 2014Artigo -
18
The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma por Sadhana Jackson, Jon Weingart, Edjah K. Nduom, Thura T. Harfi, Richard T. De George, Dorothea McAreavey, Xiaobu Ye, Nicole M. Anders, Cody J. Peer, William D. Figg, Mark R. Gilbert, Michelle A. Rudek, Stuart A. Grossman
Publicado em 2018Artigo -
19
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma por Kaisorn L. Chaichana, Ignacio Jusué-Torres, Rodrigo Navarro-Ramírez, Shaan M. Raza, María Pascual-Gallego, Aly Ibrahim, Marta Hernandez-Hermann, Luis Miguel Marín Gómez, Xiaobu Ye, Jon Weingart, Alessandro Olivi, Jaishri O. Blakeley, Gary L. Gallia, Michael Lim, Henry Brem, Alfredo Quiñones‐Hinojosa
Publicado em 2013Artigo -
20
Phase I Trial of Temozolomide Plus <i>O</i><sup>6</sup>-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma por Jennifer A. Quinn, Annick Desjardins, Jon Weingart, Henry Brem, M. Eileen Dolan, Shannon M. Delaney, James J. Vredenburgh, Jeremy N. Rich, Allan H. Friedman, David A. Reardon, John H. Sampson, Anthony E. Pegg, Robert C. Moschel, Robert Birch, Roger E. McLendon, James M. Provenzale, Sridharan Gururangan, Janet Dancey, Jill Maxwell, Sandra Tourt-Uhlig, James E. Herndon, Darell D. Bigner, Henry S. Friedman
Publicado em 2005Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Internal medicine
Surgery
Cancer research
Glioma
Chemotherapy
Glioblastoma
Temozolomide
Oncology
Biology
Pathology
Proportional hazards model
Radiation therapy
Radiology
Biochemistry
Carmustine
Central nervous system
Cyclophosphamide
Gene
Neurosurgery
Perioperative
Pharmacology
Survival analysis
Alternative medicine
Anesthesia
Astrocytoma
Cancer
Clinical trial
Concomitant
Disease